Travere Therapeutics Ownership | Who Owns Travere Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Travere Therapeutics Ownership Summary

Travere Therapeutics is owned by 35.07% institutional investors, 0.74% insiders, and 64.19% retail investors. Blackrock is the largest institutional shareholder, holding 9.86% of TVTX shares. Delaware Small Cap Core I is the top mutual fund, with 4.42% of its assets in Travere Therapeutics shares.

TVTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Travere Therapeutics	35.07%	0.74%	64.19%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	7.64M	9.86%	$62.84M
Blackrock funding, inc. /de	8.10M	9.11%	$193.60M
Armistice capital	6.72M	7.56%	$160.70M
Vanguard group	6.61M	7.44%	$158.06M
Macquarie group	4.98M	5.60%	$119.13M
Janus henderson group	4.06M	5.22%	$70.69M
Perceptive advisors	3.79M	4.27%	$90.69M
Adage capital partners gp	3.55M	3.99%	$84.89M
State street	3.22M	3.62%	$76.91M
Fmr	2.89M	3.25%	$69.17M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Rock springs capital management lp	2.16M	3.02%	$51.74M
Perceptive advisors	3.79M	2.62%	$90.69M
Knott david m jr	260.00K	2.51%	$6.21M
Armistice capital	6.72M	2.38%	$160.70M
Eversept partners, lp	1.42M	2.33%	$33.87M
Exome asset management	156.92K	2.27%	$3.75M
Kynam capital management, lp	949.73K	1.69%	$22.70M
Emerald advisers	2.15M	1.64%	$51.31M
Emerald mutual fund advisers trust	1.20M	1.48%	$28.70M
Superstring capital management lp	53.63K	1.26%	$1.28M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	4.06M	0.04%	4.03M
Perceptive advisors	3.79M	2.62%	2.96M
Fmr	2.89M	0.00%	1.83M
Stephens investment management group	1.60M	0.50%	1.60M
Wellington management group llp	1.20M	0.01%	1.17M

Top Sellers

Holder	Shares	% Assets	Change
Viking global investors lp	-	-	-2.60M
Armistice capital	6.72M	2.38%	-2.15M
Finepoint capital lp	-	-	-1.78M
Assenagon asset management	93.36K	0.00%	-1.01M
Logos global management lp	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Stephens investment management group	1.60M	0.50%	1.60M	$38.23M
Arrowstreet capital, limited partnership	328.65K	0.01%	328.65K	$7.85M
Jump financial	315.03K	0.09%	315.03K	$7.53M
Neuberger berman group	211.67K	0.00%	211.67K	$5.06M
Ikarian capital	190.78K	0.46%	190.78K	$4.56M

Sold Out

Holder	Change
Twin peaks wealth advisors	-1.00
Nelson, van denburg & campbell wealth management group	-14.00
Ifp advisors	-17.00
Global retirement partners	-19.00
Stephens consulting	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	97	-54.46%	31,195,759	-67.08%	35	0.31%	55	-52.17%	27	-59.09%
Jun 30, 2025	221	-4.74%	100,360,560	2.40%	112	0.92%	115	-13.53%	71	20.34%
Mar 31, 2025	11	-94.74%	4,535,953	-95.23%	5	0.03%	5	-96.12%	3	-94.12%
Dec 31, 2024	107	-42.47%	35,070,340	-57.58%	45	0.40%	66	-30.53%	23	-58.93%
Sep 30, 2024	185	5.11%	82,651,760	-6.09%	106	0.82%	96	-6.80%	54	14.89%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Delaware Small Cap Core I	3.45M	4.42%	-21.39K
Macquarie Small Cap Core I	3.36M	3.77%	-252.48K
Vanguard Total Stock Mkt Idx Inv	2.79M	3.13%	-61.84K
Aviva Investors GlConvtAbsRet I USD Acc	2.20M	2.88%	-229.35K
Vanguard US Total Market Shares ETF	2.51M	2.82%	-
iShares Russell 2000 ETF	2.13M	2.39%	-
Janus Henderson Global Life Sciences	1.76M	1.98%	510.24K
Janus Henderson Global Life Sciences D	1.76M	1.98%	173.21K
SPDR® S&P Biotech ETF	1.51M	1.69%	3.37K
Janus Henderson Glb Life Scn I2 USD	1.50M	1.69%	53.07K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 01, 2025	Cline Christopher R.	CHIEF FINANCIAL OFFICER	Sell	$700.20K
Nov 04, 2025	Calvin Sandra	SVP, CHIEF ACCOUNTING OFFICER	Sell	$2.42M
Oct 31, 2025	Coughlin Timothy	-	Sell	$630.60K
Oct 31, 2025	Heerma Peter	CHIEF COMMERCIAL OFFICER	Sell	$195.69K
Oct 29, 2025	Dube Eric M	CHIEF EXECUTIVE OFFICER	Sell	$817.07K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	7
2025 Q3	-	5
2025 Q2	-	6
2025 Q1	-	26
2024 Q4	-	4

TVTX Ownership FAQ

Who Owns Travere Therapeutics?

Travere Therapeutics shareholders are primarily institutional investors at 35.07%, followed by 0.74% insiders and 64.19% retail investors. The average institutional ownership in Travere Therapeutics's industry, Biotech Stocks , is 45.22%, which Travere Therapeutics falls below.

Who owns the most shares of Travere Therapeutics?

Travere Therapeutics’s largest shareholders are Blackrock (7.64M shares, 9.86%), Blackrock funding, inc. /de (8.1M shares, 9.11%), and Armistice capital (6.72M shares, 7.56%). Together, they hold 26.53% of Travere Therapeutics’s total shares outstanding.

Does Blackrock own Travere Therapeutics?

Yes, BlackRock owns 9.86% of Travere Therapeutics, totaling 7.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.84M$. In the last quarter, BlackRock decreased its holdings by -152K shares, a -1.95% change.

Who is Travere Therapeutics’s biggest shareholder by percentage of total assets invested?

Rock springs capital management lp is Travere Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.02% of its assets in 2.16M Travere Therapeutics shares, valued at 51.74M$.

Who is the top mutual fund holder of Travere Therapeutics shares?

Delaware Small Cap Core I is the top mutual fund holder of Travere Therapeutics shares, with 4.42% of its total shares outstanding invested in 3.45M Travere Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools